Astrantus’s RenaissanceRe RNR Stock Holding History

Astrantus’s Portfolio RNR Stock Details RNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,967	Closed	-$672K	–	281
2021 Q4	$672K	Buy	+3,967	New	+$621K	0.5%	82

Other funds holding RNR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GCM

Gladstone Capital Management London, United Kingdom $1.01B AUM 74.88% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return

Astrantus's RNR Position: Q1 2022 in Review

Astrantus sold out of RenaissanceRe (RNR) in Q1 2022, closing a stake of 3,967 shares — an estimated $672K sold.

Astrantus first reported a position in RNR in Q4 2021 and held it in 1 quarter. The position peaked at $672K in Q4 2021. 319 funds tracked by Wall St. Rank hold RNR as of Q1 2022.

Astrantus reported no remaining RenaissanceRe position as of Q1 2022 after selling out during the quarter.
Astrantus sold 3,967 RenaissanceRe shares in Q1 2022, an estimated $672K.
Astrantus first reported a position in RenaissanceRe in Q4 2021 and held it in 1 quarter.
Astrantus's RenaissanceRe position peaked at $672K in Q4 2021.
319 funds tracked by Wall St. Rank held RenaissanceRe as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.